Abstract

This abstract highlights the innovative use of Enzyme-Linked Immunosorbent Assay (ELISA) techniques for rapid point-of-care testing, showcasing its potential to break barriers in healthcare accessibility and diagnostics. Traditional ELISA assays, known for their high sensitivity and specificity, have been adapted and optimized for point-of-care settings, allowing for rapid and accurate detection of various biomarkers at the patient’s bedside or in resource-limited settings. This abstract explores the key advancements in ELISA technology that enable rapid point-of-care testing, including simplified assay formats, portable instrumentation, and user-friendly workflows. Additionally, it discusses the diverse applications of point-of-care ELISA in infectious disease diagnosis, chronic disease management, and global health initiatives. By bringing laboratory-quality diagnostics to the point of care, ELISA techniques are poised to revolutionize healthcare delivery, particularly in underserved communities and low-resource settings, thereby breaking barriers to timely and effective healthcare access.